Associate Director, Global Patient Advocacy
Pubblicato il 12-08-2026 - Initial Therapeutics in Italia
Build our future together:
Vuole saperne di più su questo lavoro? Scorra verso il basso per scoprire quali competenze, esperienze e titoli di studio sono necessari.
At Regeneron, we use science and innovation to develop life‑changing medicines for people with serious diseases. We are seeking an Associate Director, Global Patient Advocacy, Hematology‑Oncology to cover International and US markets. In this role, you will lead the development and execution of patient advocacy strategies, building meaningful relationships with advocacy groups and professional societies to support patient needs and business objectives, while collaborating with cross‑functional leaders (Medical Affairs, Market Access, Marketing, and Policy teams). This position offers the opportunity to contribute to a fast‑growing, science‑driven organization making a meaningful difference to patients worldwide.
When & where:
UK, Germany, Italy or Spain (Hybrid model); Travel: 40%+.
Discover your role:
-
- Lead advocacy and engagement strategy for Hematology‑Oncology in Europe.
- Partner with senior cross‑functional leaders to build advocacy strategies.
- Build and manage relationships with patient advocacy groups and professional societies.
- Oversee patient engagement initiatives, meetings, and communications.
- Develop frameworks to embed the patient perspective across organizational processes.
- Track and report outcomes of advocacy initiatives to senior leadership.
- You foster collaboration and consensus among diverse stakeholders.
- You drive a patient‑centric culture and influence strategic decisions.
This role requires:
-
- Undergraduate degree required.
- 10+ years of industry or relevant professional experience.
- 5+ years of patient advocacy, stakeholder engagement, and issues management.
- European, international, or global advocacy experience and understanding of relevant regulations (e.g., EMA, HTA).
- Proven leadership in developing and executing advocacy strategies.
- Country‑leve